- Kodiak Sciences stock jumped 145% after Zenkuda and KSI-501 hit Phase 3 goals in wet AMD.
- The late-stage trial success is a clinical milestone for Kodiak Sciences in wet AMD.
Quotes
“Kodiak Sciences stock jumps 145% as Zenkuda and KSI-501 hit Phase 3 wet AMD goals.”